Integrated Protocol Composed (Figure 1) - 1) Registry 2) 3) 4) Chemistry Protocol Scheduling 6) Recording 7)

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 4

AN INTEGRATED CLINICAL PROTOCOL MANAGEMENT SYSTEM

Richard B. Friedman, M.D., Steven Entine, G. Malcolm Murray,


David Holladay, and Carol E. Steinhart

Department of Human Oncology, University of Wisconsin


Madison, Wisconsin

The rapid increase in the number and The integrated protocol management system
complexity of combined modality and multiple is composed of a number of individual systems
therapeutic agent therapy in protocol based linked through a central minimal data set
treatment of disease has resulted in increased (figure 1). The individual components include:
reliance on manual and automated data base 1) a tumor registry; 2) an outpatient clinic
management systems. At many clinical research appointment system; 3) a hospital admission
centers multiple computerized data base systems notification system; 4) a chemistry and
are used to keep track of patients on various hematology laboratory results storage and
treatment protocols. This has resulted in retrieval system; 5) a clinical protocol
redundant data entry and often hinders cross scheduling system; 6) clinical data recording
data base correlations. system; and 7) research data bases. These
are all linked through pointers in a minimal
An integrated protocol management system data set which includes the following infor-
is described which utilizes a common minimal mation on each patient:
data set to facilitate patient identification,
eliminate duplicate data entry, and promote 1) name
cross data base correlations. The system 2) history number
is currently in use at a clinical cancer 3) date of birth
center and has resulted in significant savings 4) sex
in data entry and data manipulation and has 5) date first seen
assisted in monitoring protocol compliance. 6) site of tumor
7) laterality of tumor
8) histology of tumor (including morphol-
ogy, behavior, and grade)
The increasing number of clinical protocols 9) stage of tumor
available for the treatment of various diseases 10) whether this is an analytic case (i.e.,
has resulted in the rapid proliferation of initial course of therapy given at this
systems for the entry, manipulation, storage, hospital)
and retrieval of clinical data. This in turn 11) followup information
has brought about the large scale introduction 12) current status (i.e., alive or dead)
of computerized data base systems in clinical
data management. This has been particularly The component data bases can each be
apparent in the area of cancer treatment accessed separately or through the minimal data
protocols since a major cancer research cen- set. This-promotes individual data base
ter may at one time have hundreds of patients integrity as well as permitting additional
under treatment on as many as fifty to one clinical research data bases to be added to the
hundred different protocols. system without the necessity of re-entering
all the identifying information in the minimal
While the introduction of computer data base data set or information already contained in
management systems into this area has resulted other data bases.
in substantial savings to the clinicians and
data managers who must collect, store, and then Tumor Registry
analyze this data; the unchecked proliferation
of multiple independent data systems at a single The hospital tumor registry contains over
center can result in redundant data entry and seventy pieces of information on each cancer
a loss of ability to correlate across data patient seen at the medical center. In addition
systems. To eliminate data redundancy and to the information contained in the minimal
facilitate cross data base retrievals we have data set the registry contains information on
instituted an integrated cancer data system sites of tumor metastases, contact addresses,
which utilizes a centralized minimal data set mode of therapy, etc. The registry is main-
which is common to all components and in turn tained as an independent data base and all
contains pointers to individual data files. retrievals can be done utilizing only this

81 CH1480-3/79/0000-0081$00.75 ©) 1979 IEEE


data base. Entries and updates are communicated can be combined with information on stage and
automatically to the central file (where histology contained in the tumor registry for
appropriate). detailed evaluations. By combining the infor-
mation in these two data bases one can determine
Clinic Appointment System if, for example, a particular community based
program on the early detection of breast cancer
The clinic appointment system is maintained has resulted in the subsequent referral of the
as a wholly independent system to permit com- breast cancer patients from that area at an
puter based clinic scheduling in the oncology earlier stage of disease.
outpatient clinic. A complex and highly sophis-
ticated system permits scheduling of appoint-
ments by date, hour, and clinician. It provides Laboratory Test Result Data Base
flexible appointment blocks depending on a
clinician's work output as well as the require- All chemistry and hematology test results
ments of an individual patient visit. The on patients seen at the medical center are
system automatically generates daily, weekly, stored on magnetic tapes. This information
and monthly physician and clinic appointment is identified by patient history number and
schedules so the clinicians can review his/her result date and can be retrieved using a 4
schedule prior to the start of a clinic (figure specially built hierarchical data base system
2). In addition, it provides administrative This system is integrated with the other data
data to the clinic director to facilitate bases using information contained in the minimal
patient load equalizing and work load reschedul- data set. Therefore, retrievals of laboratory
ing in the event that a clinician must cancel data by individual patient name, history number,
a clinic. tumor site, histology, stage, etc. are possible.
In addition, by integrating this system
with the minimal data set one can facilitate Protocol Schedule System
positive patient identification, treatment
protocol planning, and order protocol mandated During the past five years there has been
tests or therapies prior to the clinic visit. a marked shift towards the use of combined
In cmnjutnction with the separate protocol modality and multiple chemotherapeutic agent
scheduling and tumor registry data systems it therapy in the treatment of disseminated
permits the automatic notification of malignancies. The development of these multiple
physicians involved in a protocol study or those therapy regimens has necessitated the intro-
looking for patients with a specific tumor when duction of strictly controlled treatment
those patients are due to return for a clinic protocols to permit comparison of different
visit. treatment programs. The introduction of in-
creasingly complex rules for modifying drug
dosages on the basis of changing test parameters
Hospital Admission Notification System has further enhanced the need for strict
protocol management. At the major cancer cen-
When an oncology patient is admitted to the ters patients on as many as 50 to 100 different
hospital the patient's name and history number treatment protocols may be followed simultan-
are checked against the minimal data set and if eously. In addition, most of these patients
not found a new patient entry is made. In will be treated during frequent clinic visits
addition to the information in the minimal data during which their contact with the oncology
set the referring physiciads name as well as staff may be quite brief. This large number
the patient¶s -ward and the attending physician of differing and complex treatment protocols
are recorded. If the patient has been pre- places a large burden on those persons who are
viously seen in the clinic or hospital, only the responsible for scheduling clinic visits,
current ward and attending physician are added. ordering the appropriate tests, modifying
The system then automatically generates a letter therapy dosages and recording appropriate
to the referring physician (figure 3) notifying clinical and research data. Errors in drug
him of the patient's admission and detailing dosage could prove detrimental; failure to
the patient's room number, the attending order appropriate studies can result in pro-
physician's name, and a toll free number to call longing important clinical studies.
for further information. If the patient has
been previously admitted, letters are automat- A clinical protocol scheduling system has
ically generated to all attending physicians been developed which facilitates handling of
at the center who had previously taken care of protocol patients on both an inpatient and
the patient notifying them of the current outpatient basis. The system utilizes the
admission. Periodic reports are generated minimal data base to permit unique patient
indicating referral patterns to the medical identification based on history number, full
center over sequential six month periods. These name or soundex name matching. The integrated
reports indicate referrals by physicians, city, clinic appointment and hospital admission
and health service area. These reports are systems facilitate both patient and laboratory
useful to determine the impact of various out- test scheduling. This permits the clinic staff
reach programs. Referral pattern information

82
to determine work schedules, length of time Research Data Bases
for an appointment, and laboratory test
requirements. Individual research data bases can be con-
When a patient is placed on a cancer pro- structed utilizing the WISAR data base system .
tocol, a unique test requirement and therapy This highly flexible system permits easy data
schedule is generated for that patient based base definition, generation storage and re-
on the date he began therapy (figure 4a,4b). trieval. Researchers can develop their own
(Provision is made for the staff to adjust special data bases to study particular clinical
cycle dates if a patient's treatment program problems. Data bases dealing with hormonal
requires modification due to the patient's markers, bone density, ancillary clinical data
condition, drug reactions, etc.) Copies of etc., have already been developed. By inte-
this schedule are then used to plan clinic grating these data bases through the central
visits and to determine what test must be order- minimal data system the need to re-enter patient
ed at each visit and when therapies must be identification data is negated and positive
altered. A list of tests to be compiled as well identification for each patient is facilitated.
as an identification for the study protocol
appears on the daily clinic schedule and the
doctor's appointment list. Individual lists Equipment
for patients to be admitted to the hospital or
those scheduled to have tests are also printed. The system is programmed in MIIS dialect
The system itself is table driven so new of MUMPS language. The system resides on a
protocols can be added without any additional Data General C-330 computer with direct inter-
programming. face to the University's UNIVAC 1100/80 for
large scale data storage and manipulation.
In linking the appointment and protocol The minimal data set is hierarchical in nature
systems in an integrated data management system, with the overall physical disk storage strategy
we can automatically notify staff personnel dictated by the B-tree scheme inherent in the
whenever an appointment is made for a study MIIS language. The overall computer config-
patient, whether that appointment results from uration consists of two identical Data General
a scheduled protocol visit or is patient C-330 computers supporting a total of 45
initiated due to a change in clinical condition. terminal ports of which approximately 20 are
This prior notification permits the staff to dedicated to this integrated data management
carefully review the patient's chart before the system.
visit to determine that all protocol dictated
tests are ordered and correct drug dosages
administered. The system is also interfaced Discussion
with specialized data sets and the hospital
tumor registry to assure early and comprehensive The integration of multiple data bases
case finding. into a unified data system linked through a
minimal data set has multiple advantages:
1) it permits positive patient data identi-
Protocol Data Recording System fication for each data system since the minimal
data set allows identification by name, history
As the results of tests or therapy modifi- number, or soundex search. It contains date
cations required by a clinical protocol are of birth and sex information for further
available, they can be entered and stored in positive confirmation; 2) it eliminates data
a separate protocol data recording system. entry redundancy by locating the most frequently
Through the minimal data set this data is repeated information in a central minimal data
linked with the patient and the data and therapy set which contains pointers to the individual
requirements of that patient's treatment pro- data bases; 3) it facilitates data searches
tocol. If tests or therapy modifications across data bases by linking data elements
indicated by the protocol are not completed through the common centralized data core.. In
by the specified date, the system's tabular this way the power of the individual systems
display (figure 5) makes it easy for the data are greatly enhanced and multiple clinical
manager to spot this deficiency and contact the correlations facilitated; 4) it greatly
appropriate clinician. facilitates clinic treatment scheduling by
automatically generating a list of protocol
Since the laboratory data system could be requirements for each study patient's visit;
linked directly with this data recording system, and 5) it makes it possible to easily monitor
data could be passed directly from the labora- protocol compliance by making it possible for
tory data base to the protocol recording system clerical personnel to keep track of the tests
without the need for manual re-entry of the or therapies required at each stage of protocol
data. management.

83
References
1) McClatchie, G.: A method of updating a
8:15 803774 KENT, CLARK WBC,PLT
cancer treatment database system. 8:30
8:45
103147
792311
DOE, MARY
JONES, WALTER
WBC,PLT,SMA12,CEA
ECG,BLOODS IN CLINIC,SKIN
Comput. Biomed. Res. 8:222-231, 1975. TESTS,CXR,ECOG EST1673 C-20 D-29
9: 00 749794 KENT, CLARK BCG,BLOODS IN CLINIC,SKIN
TESTS,CXR,ECOG EST1673 C-11 0-1
C07 6TI
2) Weyl, S., Fries, J., Wiederhold, G. and 9:15 800930 DOE, JOHN CXR,SKIN TESTS,BLOODS IN
CLINIC EST1673 C-8 D-1
9I30 799080 DOE, MARY NO EST1673 C-3 D-25
Germano, F.: A modular self describing 9:45 763839 LOE, JOHN CXR,SMA12,QUANT BL COMP,
WBC,PLT,SKIN TESTS,IN VITRO
clinical data base system. Comput. TESTS,ECOG EST1673 C-9 D-22
10:00 465191 SMTTH, WALTER NO
Biomed. Res. 8:279-293, 1975. 10:1S 761605 DOE, MARY LANG TOMO 9,(6E),NO

FIGURE 2
3) Blum, B.J., Lenhard, R.E., Braine, H. and WISCONSIN CLINICAL CANCER CENTER CEC
Hammer, A.: A clinical information display U N. 1300 U-iA-9 lEN INK1 53A 6 ONCOLOGY C-IAYIC
system. In Proceedings of the First C -.oP.,.,
A A8 - 262 -A622

Symposium on Computer Applications in


Medical Care, Washington, D.C., Oct., 1977.
May 14, 1979

4) Soffer, S., Entine, S., Wolfe, T., Eggert, Dr. Ron-ld M, Donald
A., Friedman, R.: Archival storage of 123 W1. Ri-
R-d
Slou- City, I,, 66666
clinical laboratory data. Clinical D,e- 0-. Mc: Donald
Chemistry 24(3):436-441, 1978. Y.", patet'
Hoptl
on
lr et vsamte
zaIYC16, lH979. owr D6/ inUivrity
Th attendin,g p ys icia is / Dr. rieUmi...
.h. c.. Lbe --ahed at (508)-263-2345. The -eident on he -ad
lsDI. LivingIston wh.s nuaber is 2S3^3215 ma lo ec
these, physicias by usFinq the toll-free n.b,r: (80,3)-362- go25.
Yo
5) Entine, S.M., Friedman, R.B., WISAR-A MUMPS YA- w1Ncl E ill be tNrnd as qEilNkly as M-sibl-
data base system which utilizes non-prime At
Il.tter
the. cnlso
etil-ng the.
of
n pt.1 cours
you p.ti-nt' h.spit.l
and -
stay,
stion
y.. willreiv
for fureher thLr-py.
a

time. 1978 MUMPS User's Group Meeting,


San Francisco, California, June, 1978.
P Carbo.
NTV M.D A
De,r-"nS
of t4dicine.
..d H.... Onlcology
FltCURE

This work was supported in part by NIH-NCI- PPC:miis

CA-14520 from the National Cancer Institute.


13I00ATA PlRaO7WL SYSTEM
PATIENT 'SHINGItA,GERGE - ess
CLINIC LABORATORY PRINY 8RY KIDNEY
A PPOI NTMENT DATA TEST PR1AIRCOL LS3877 REG6"1N: ACTRD
SYSTEM RESUILT SYSTEM Ul PHYSEC JAN OR. <:ED LWAE k1RFAC1.7'i M2

HOSPITAL.. US1
TW9R
L APY FOR THIS RsGIMEN
ADMI SS ION\ /
NOTTFICATION DIV - ORCIDUNAlL STUDIES ACT-D rIv. e5 r,m2 D) 1-4
\- < / i S m ~~~~INVESTIGATORS
DOSGE YODIFICATICN
MNMAL \ MLJST OIPLETE 2 CYCLES
CLINICAL I|
DATA FAIWIRE :RERANDCM IZE TO ONE OF, REmiN m TReAitEwrs
PROTOCOL SET WH <4000 OR PLT <10l6,0U: OElJAY ORLCS L4lai. HBC>4ffl AND PLT>169eeve
SCH EDU LI NG \~ I'M N,DIR 1S3N AND PLT NK.N R >1681,*86:
rNCR 25% 1RUGS
(ONE ESCALATION ONLY)

SYSTEM1 18C N6DIR <298 AND PLT NADIR


PLT N8DIR <75,0066
SEV8ERE NAUSEA
SEERE SrONTIYTIS:
58S
A"9')"rr8G:
e56 DRUGS
DR8GS >7s,0Ne
75%
set DRUGS
DRU2S

I LDNI CAL
PROTOCOL "MC
TUO DRLIG DATEM DOSE COMPLIANCE
RESULTS REGIS TRY
RECORD I NG
SYSTEM

BIIYTA PF47lCOL SYS70 FIGURE lb


PATIEllr WfiSHDG101 *55s t3 DITA i1etaDUL SYSXT
PtX)OCL EST3877 Rf£LKEN2 0
PATRIW 818888888E88, - 655
Ulf SHYICIAti PRWL^Y K1IOZEY
TeST ~ NINE.-
AUG. 1LINER
AMG. 8 ~ ALUG. ~
15 kW.~ 22 ~AM;. 29O CINCA
SEP. S PICQOCL EST3877 RKSTM: ACr-
CYCLEDY lC-1 D-1 IC-1 D-8 C-1 D-15 IC-1 D-22 «C-2 D-1 tC-2 D-8 WU PHYSICIAN
TEST AuG. 1A2G.78 AG. 15 AUG. 22 AUG. 29 SEP. 5
fILM
_ C-1 D1I C-1 D8 C-1D-15 jC-1 D22 C-2 D-1 C-2 D-I
5666 8N2 9182 ININ -fS

BOE SAa|T
wLIVRSAaf

7U" EAS

weApY
CYLE-YT
a A NOCTE

K.I
- -
F lSAT

AG
Cl08
V.I
I- 1
A;
CI02
2 tC
C201
9 sP
t- -
NBCK
PLT
MGM"

CWART
V1."
Is9,qw
18.

1.8
4924
112, 374 99, e69
3382 310
10. 046

BONE X PaS_ _
BRAIN SCANN 8EG
LrVER SCa IES_

a.AS INDICATED FIOR DlS&ASE ASSESSIENr

lumEAPYNIN NIG. AUG. 8 AUG. 15 At1G. 22 ALG. 29 SEP. 5


CYCLE-D-Y D-1 ic-1D-8 EC- D-15 iC-1 D-22 f-2 D-1 1-2 D-8
ACTDc8- .75 G

84

You might also like